Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
Số trang: 10
Loại file: pdf
Dung lượng: 1.56 MB
Lượt xem: 9
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Nivolumab and pembrolizumab have not been directly compared in clinical trials, and the aim of this study is to investigate the efficacy and safety of nivolumab versus pembrolizumab in patients with advanced hepatocellular carcinoma (HCC) in real-world practice.
Nội dung trích xuất từ tài liệu:
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
Nội dung trích xuất từ tài liệu:
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Hepatocellular carcinoma Real-world practice Real-world comparison Advanced hepatocellular carcinoma Overall survivalTài liệu có liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 179 0 0 -
6 trang 171 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 150 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 135 0 0 -
12 trang 103 0 0
-
19 trang 81 0 0
-
17 trang 71 0 0
-
9 trang 48 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 43 0 0 -
9 trang 42 0 0